fashion -WSS

fashion

author：comprehensive 2025-10-02 03:02:50 - browse：71

Chief executive officer of Sanofi Paul Hudson, wearing glasses, speaks into a mic — pharma coverage from STAT — Sanofi CEO Paul Hudson Carolyn Kaster/AP

LONDON — Sanofi CEO Paul Hudson on Wednesday defended his company’s recent moves to abandon future profit guidance and up its investment in its own research programs, arguing that the dramatically negative market response didn’t reflect the potential rewards that could stem from the plan.

“Would I have liked the stock market reaction to be more generous? Of course,” Hudson said at a Financial Times event in London. “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division. As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. Company executives have argued that this was the moment — when Sanofi has a strong pipeline and isn’t facing patent expirations for years — to increase its R&D resources, even at the expense of short-term profits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： BIO to announce reorganization, senior leaders expected to depart

hotspot

WSS

No plane should take off without an EpiPen onboard

Trump indictment: Who are the 'co

AltruBio raises $225 million to develop ulcerative colitis drug

What to expect as Trump is arraigned on his Jan 6. indictment

Class action alleges UnitedHealth concealed DOJ probe

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

knowledge

fashion

focus

Cancer drug shortages should be causing more outrage

Micronoma's microbiome cancer diagnostic approach under fire

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The creative science of coining drug names

Bright Health sells Medicare Advantage business to Molina

EQRx, failed developer of low

Alkermes shareholders re

Black vets could get higher VA benefits if race not used in lung test

Apple is now the first public company to be valued at $3 trillion

Most antidepressants don't work on kids, teens, study finds

hotspot

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Welsh Carson private equity firm escapes from FTC antitrust case

New safety details link Apellis eye drug to rare cases of blindness

Breakthrough Alzheimer’s drugs are inaccessible in rural states

hotspot

hotspot

explore

focus